Capstone Investment Advisors LLC Invests $942,000 in Corteva, Inc. $CTVA

Posted by George Bondi on Aug 28th, 2026

Capstone Investment Advisors LLC purchased a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 11,128 shares of the company’s stock, valued at approximately $942,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CTVA. EFG International AG acquired a new stake in shares of Corteva during the 2nd quarter valued at $25,000. Compass Financial Management LLC acquired a new position in Corteva in the 2nd quarter valued at $25,000. JPL Wealth Management LLC acquired a new position in shares of Corteva during the third quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva in the fourth quarter valued at about $27,000. Finally, Bank of Jackson Hole Trust bought a new position in Corteva in the fourth quarter worth $28,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

Shares of CTVA opened at $82.27 on Friday. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The company has a market cap of $54.89 billion, a PE ratio of 54.48, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. The firm has a 50-day moving average of $82.58 and a 200-day moving average of $80.52. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CTVA shares. JPMorgan Chase & Co. upped their price objective on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Barclays upped their target price on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research report on Thursday, June 11th. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. BMO Capital Markets upped their target price on shares of Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Finally, Royal Bank Of Canada raised their price objective on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a report on Tuesday, July 21st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Get Our Latest Research Report on CTVA

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.